Skip to main content

and
  1. Article

    Open Access

    Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan

    Real-world clinical experience with afatinib as a treatment for advanced lung adenocarcinoma harboring uncommon epidermal growth factor receptor (EGFR) mutations (G719X, L861Q and S768I) has rarely been reported.

    **-Chih Hsu, Suey-Haur Lee, Li-Chung Chiu, Chung-Shu Lee in Targeted Oncology (2023)

  2. No Access

    Article

    Prognostic impact of combining whole-body PET/CT and brain PET/MR in patients with lung adenocarcinoma and brain metastases

    The role of brain FDG-PET in patients with lung cancer and brain metastases remains unclear. Here, we sought to determine the prognostic significance of whole-body PET/CT plus brain PET/MR in predicting the ti...

    Kung-Chu Ho, Cheng-Hong Toh, Shih-Hong Li in European Journal of Nuclear Medicine and M… (2019)

  3. Article

    Open Access

    One-year mortality among hospital survivors of cholinesterase inhibitor poisoning based on Taiwan National Health Insurance Research Database from 2003 to 2012

    Acute cholinesterase inhibitor (CI) poisoning, including organophosphate and carbamate poisoning, is a crucial problem in develo** countries. Acute intoxication results in a cholinergic crisis, neurological ...

    Min-Chun Chuang, Chih-Hao Chang, Chung Shu Lee in BMC Pharmacology and Toxicology (2018)

  4. Article

    Open Access

    Diffuse alveolar damage associated mortality in selected acute respiratory distress syndrome patients with open lung biopsy

    Diffuse alveolar damage (DAD) is the pathological hallmark of acute respiratory distress syndrome (ARDS), however, the presence of DAD in the clinical criteria of ARDS patients by Berlin definition is little k...

    Kuo-Chin Kao, Han-Chung Hu, Chih-Hao Chang, Chen-Yiu Hung, Li-Chung Chiu in Critical Care (2015)